{
    "2021-01-06": [
        [
            {
                "time": "",
                "original_text": "人福医药(600079.SH)：注射用盐酸瑞芬太尼通过仿制药一致性评价",
                "features": {
                    "keywords": [
                        "人福医药",
                        "注射用盐酸瑞芬太尼",
                        "仿制药",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业一周观察：国药新冠疫苗附条件获批上市 紧握创新龙头",
                "features": {
                    "keywords": [
                        "医药行业",
                        "国药",
                        "新冠疫苗",
                        "附条件获批",
                        "创新龙头"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}